Solventum Corp | SOLV - Ebitda

Aktienkurs
74.47
Täglich Wechseln
0.05 0.07%
Monatlich
8.12%
Jährlich
0.49%
Q2 Prognose
71.86




Ebitda Veränderung Datum
Abbott USD 3.27B 178M 2025-12
Align Technology USD 260.87M 77.03M 2025-12
Baxter International USD -447M 873M 2025-12
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Cencora USD 1.2B 42.41M 2025-12
Dexcom USD 364.5M 57.7M 2026-03
Insulet USD 181.7M 12.3M 2026-03
Solventum Corp USD 437M 0 2026-03
West Pharmaceutical Services USD 226.2M 7.7M 2026-03
Zimmer Biomet Holdings USD 759M 120.8M 2025-12